This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Seminoma of testis
C3_TESTIS_SEMINOMA
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly males |
226837 |
2. Check conditionsNone |
226837 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
362 |
4. Check minimum number of eventsNone |
362 |
5. Include endpointsNone |
362 |
6. Filter based on genotype QC (FinnGen only) |
362 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Seminoma of testis
based on the number of shared cases.
Similar with more cases:
- Seminoma of testis, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)
- malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 362 | - | 362 |
| Unadjusted period prevalence (%) | 0.16 | - | 0.16 |
| Median age at first event (years) | 37.93 | - | 37.93 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 328
- Matched controls
- 3280
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
+∞
309.6
246
*
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
+∞
264.9
217
*
KFC00
NOMESCO Finland
Unilateral orchiectomy
581.9
255.8
224
12
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
444.8
197.7
180
9
JN4BD
NOMESCO Finland
Extensive body CT
14.8
74.6
137
151
9061/3-C62.1
ICD-O-3
Seminoma, NOS, of descended testis
+∞
63.6
59
*
C62.10
ICD-10 Finland
Malignant tumor of the descending testicle, no histological verification
351.9
59.3
58
*
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
20.7
57.5
88
57
C62.1
ICD-10 Finland
Malignant neoplasm: Descended testis
+∞
49.2
46
*
C62.91
ICD-10 Finland
Malignant tumor in unspecified location in testis, seminoma
+∞
41.5
39
*
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
159.9
40.8
42
*
130
Kela drug reimbursment
Malignant tumour
8.4
37.6
90
141
C62.01
ICD-10 Finland
Malignant tumor of the non-descending testicle, seminoma
+∞
36.1
34
*
JN4AD
NOMESCO Finland
Body CT examination
8.9
33.6
76
107
A03FA01
ATC
metoclopramide; systemic, rectal
5.8
32.7
107
254
7511
FHL
Orchidectomy (unilateral), also includes funicularectomy
126.0
32.3
34
*
18699
ICD-8 Finland
Malignant neoplasm of testis
331.3
30.3
30
*
C62.12
ICD-10 Finland
Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
88.5
29.3
32
*
C62.90
ICD-10 Finland
Malignant tumor in unspecified location in testis, no histological verification
306.3
28.2
28
*
C62.99
ICD-10 Finland
Malignant tumor in unspecified location in testis,other or undetermined histology
306.3
28.2
28
*
C62.19
ICD-10 Finland
Malignant tumor of the descending testicle, other or undetermined histology
109.7
28.2
30
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.5
25.1
187
908
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.8
25.0
77
164
121
Kela drug reimbursment
Severe hypofunction of sexual glands
22.1
23.6
34
17
C62.00
ICD-10 Finland
Malignant tumor of the non-descending testicle, no histological verification
+∞
23.2
22
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
24.5
18.0
25
11
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.0
17.9
138
640
1869A
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),SEMINOMA]
+∞
17.9
17
*
JN3AD
NOMESCO Finland
Abdominal CT examination
5.4
17.6
55
117
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
8.5
17.2
38
50
A04AA02
ATC
granisetron; systemic, transdermal
7.0
15.3
38
60
L03AA02
ATC
filgrastim; parenteral
14.1
15.0
25
19
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
22.3
14.9
21
10
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
15.1
14.8
24
17
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
4.4
14.6
55
142
WX408
NOMESCO Finland
General anesthesy, balanced
2.9
14.1
106
470
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.7
13.3
63
200
H02AB02
ATC
dexamethasone; systemic
4.5
12.3
44
108
D29.2
ICD-10 Finland
Benign neoplasm: Testis
48.5
12.0
14
*
E29.1
ICD-10 Finland
Testicular hypofunction
7.4
11.6
27
39
C62.9
ICD-10 Finland
Malignant neoplasm: Testis, unspecified
+∞
11.5
11
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
124.2
11.5
12
*
9085/3-C62.9
ICD-O-3
Mixed germ cell tumor of testis, NOS
124.2
11.5
12
*
Y78
ICPC
Malign neopl male genital other
+∞
10.5
10
*
C62
ICD-10 Finland
Malignant neoplasm of testis
+∞
10.5
10
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
41.4
10.0
12
*
C62.92
ICD-10 Finland
Malignant tumor in unspecified location in testis, embryonic carsinoma, teratocarcinoma or coriocarsinoma
102.9
9.5
10
*
C62.0
ICD-10 Finland
Malignant neoplasm: Undescended testis
+∞
9.4
9
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.8
9.2
61
244
WX320
NOMESCO Finland
Spinalanesthesy
2.6
9.0
75
341
N46
ICD-10 Finland
Male infertility
5.2
8.9
27
56
N02AA05
ATC
oxycodone; systemic
3.0
8.9
54
204
KFA00
NOMESCO Finland
Exploration of testis
28.4
8.5
11
*
A04AA01
ATC
ondansetron; systemic, rectal
5.0
8.5
26
55
7513
FHL
Test prosthesis installation
92.3
8.5
9
*
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
11.2
8.4
15
14
C62.02
ICD-10 Finland
Malignant tumor of the non-descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
8.4
8
*
1869X
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),EI HIST VAHV]
+∞
8.4
8
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
11.2
7.9
14
13
D70.82
ICD-10 Finland
Drug-induced neutropenia
10.4
7.6
14
14
N02BE01
ATC
paracetamol; systemic, rectal
2.1
7.6
263
2146
2395A
ICD-9 Finland
Neoplasm of unspecified nature, Other genito-urinary organs
81.9
7.4
8
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.6
6.8
22
50
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
40.9
6.8
8
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
7.1
6.6
15
22
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
5.0
6.3
19
40
Y28
ICPC
Limited function/disability (Y)
18.4
6.3
9
5
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
+∞
6.3
6
*
9063/3-C62.9
ICD-O-3
Spermatocytic seminoma of testis, NOS
+∞
6.3
6
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
27.2
6.3
8
*
ZX120
NOMESCO Finland
Intravenous
3.0
6.2
35
125
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.7
6.1
42
169
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.5
6.0
27
83
WZC30
NOMESCO Finland
Teaching
2.5
6.0
48
214
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
94
13
97.32
178.64
9.5
3.2
—
—
—
0
0
78
44
22.32
99.41
3.6
1.5
16.7
8.8
iu/l
2.30
69
33
106
119
12.18
90.93
3.1
1.5
7.3
4.7
u/l
2.24
94
102
153
531
4.26
39.06
4.3
2.3
13.5
15.3
nmol/l
2.31
148
497
299
2045
3.66
20.96
12.0
8.2
76.4
77.5
u/l
0.21
294
1952
236
1541
2.53
15.62
11.9
10.2
3.6
4.2
e9/l
4.42
212
1361
38
92
4.50
14.79
1.4
2.4
102.0
85.5
%
4.74
38
86
135
727
2.37
13.24
5.5
3.6
2.4
2.3
mmol/l
1.29
124
656
84
377
2.60
12.11
5.8
3.3
2.4
2.4
mmol/l
0.03
74
326
126
690
2.27
11.62
3.7
3.0
0.6
0.4
e6/l
0.21
101
529
83
400
2.39
10.14
3.6
2.9
0.4
0.5
e6/l
0.17
54
223
85
415
2.37
10.08
3.4
2.8
1.1
1.2
e6/l
0.07
56
238
149
915
2.07
9.95
3.9
3.1
—
—
—
0
0
165
1052
2.04
9.94
4.0
4.3
—
—
—
0
0
50
191
2.88
9.75
2.5
1.9
207.0
244.8
pmol/l
1.40
50
181
218
1545
2.03
9.67
5.8
5.6
6.7
6.8
mmol/l
0.20
207
1476
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
73
3.45
6.82
4.1
3.3
0.3
0.3
u/ml
0.39
12
38
155
1067
1.79
6.67
9.3
6.0
36.6
36.5
g/l
0.08
144
1005
162
1139
1.76
6.42
12.1
8.1
1.2
1.2
mmol/l
0.14
128
984
310
2662
2.15
6.20
19.6
12.0
86.4
88.3
ml/min/173m2
0.67
282
2211
90
556
1.82
5.38
1.8
1.8
1.3
1.4
mg/l
0.15
71
411
318
2822
2.04
4.82
22.0
15.2
139.4
139.7
mmol/l
1.58
311
2763
43
214
2.15
4.75
6.4
5.3
4.1
69.2
ug/l
1.05
36
181
143
1041
1.62
4.58
10.4
7.2
1.2
1.2
mmol/l
0.73
137
963
24
94
2.66
4.48
1.3
1.5
228.8
286.9
mu/l
0.93
24
88
318
2839
1.99
4.48
22.3
15.2
4.0
4.0
mmol/l
0.27
310
2780
315
2827
1.88
4.02
19.8
13.3
23.4
24.8
mg/l
0.31
259
2227
46
263
1.86
3.48
3.4
2.9
—
—
—
0
0
15
53
2.91
3.40
2.5
4.1
56.2
54.2
%
0.37
15
53
80
546
1.60
3.21
3.2
2.5
—
—
—
0
0
99
711
1.54
3.18
3.5
2.5
366.0
7779.9
umol/l
2.97
91
634
14
50
2.87
3.12
2.6
3.8
3.6
3.8
e9/l
0.11
14
50
12
40
3.07
3.00
1.2
1.1
—
—
—
0
0
268
2368
1.51
2.93
25.8
16.2
13.5
13.5
%
0.16
263
2318
19
85
2.30
2.75
1.4
1.4
—
—
—
0
0
191
1595
1.42
2.74
3.9
4.1
1.7
2.0
ug/l
0.60
169
1457
331
3090
1.83
2.70
14.4
9.8
32.3
33.9
u/l
0.85
326
3015
150
1211
1.41
2.56
3.3
3.0
0.0
0.0
estimate
0.49
31
239
151
1221
1.41
2.55
3.3
3.1
0.0
0.0
estimate
0.00
30
226
40
242
1.73
2.54
6.8
4.4
1.1
1.6
mmol/l
0.46
33
200
7
16
4.44
2.48
3.7
1.8
176.0
192.6
u/l
—
7
16
149
1209
1.40
2.45
5.1
4.2
0.0
0.0
estimate
0.00
31
248
40
245
1.71
2.44
6.8
4.4
5.9
5.8
kpa
0.04
40
239
28
156
1.86
2.33
1.8
1.4
—
—
—
0
0
26
142
1.90
2.30
2.4
1.5
—
—
—
0
0
14
60
2.39
2.24
2.7
4.1
—
3939.6
—
0
7
31
184
1.75
2.12
1.6
1.6
—
—
—
0
0
7
21
3.38
1.97
1.3
2.1
—
—
—
0
0
40
262
1.59
1.92
4.2
2.8
27.9
221.6
u/l
0.55
34
227
246
2686
0.74
1.92
4.3
3.9
6.0
6.0
mmol/l
0.04
223
2491
7
22
3.22
1.89
1.3
1.5
0.2
0.2
nmol/l
—
7
17
16
79
2.07
1.88
3.4
2.0
—
—
—
0
0
30
189
1.64
1.69
2.5
2.4
68.6
67.7
ml/min/173m2
0.03
16
78
17
91
1.91
1.63
1.1
1.2
—
—
—
0
0
55
402
1.43
1.60
2.9
1.9
—
—
—
0
0
82
644
1.35
1.57
2.9
3.2
991.5
1171.3
ng/l
0.28
70
531
24
146
1.69
1.55
1.5
1.5
—
—
—
0
0
5
15
3.36
1.53
1.4
1.2
—
—
—
0
0
5
15
3.36
1.53
1.4
1.2
—
—
—
0
0
5
15
3.36
1.53
1.4
1.2
—
—
—
0
0
5
15
3.36
1.53
1.4
1.2
—
—
—
0
0
5
15
3.36
1.53
1.4
1.2
—
—
—
0
0
7
27
2.62
1.52
1.0
1.1
—
—
—
0
0
119
991
1.30
1.51
3.3
3.1
—
—
—
0
0
6
21
2.89
1.51
1.0
1.0
—
—
—
0
0
271
2887
0.76
1.47
4.1
4.0
1.3
1.3
mmol/l
0.06
253
2714
5
16
3.15
1.44
1.2
1.3
—
—
—
0
0
44
315
1.45
1.44
4.4
3.9
8.9
12.1
umol/l
0.45
37
280
16
89
1.83
1.39
1.1
1.2
325.1
277.7
u/ml
0.27
11
58
47
345
1.42
1.35
4.8
2.5
24.6
25.3
%
0.14
41
305
0
38
0.00
1.35
0.0
1.3
—
300.0
—
0
6
276
2924
0.76
1.34
4.4
4.4
2.9
2.9
mmol/l
0.01
261
2741
102
848
1.28
1.30
3.3
2.9
54.7
57.3
u/l
0.37
93
805
6
25
2.42
1.25
4.8
1.9
—
—
—
0
0
11
56
1.99
1.23
1.5
1.6
—
—
—
0
0
11
56
1.99
1.23
2.8
1.9
—
—
—
0
0
120
1026
1.25
1.21
3.7
3.4
70.2
53.3
ng/l
0.19
84
675
6
26
2.33
1.19
1.0
1.0
—
—
—
0
0
274
2890
0.79
1.14
4.2
4.1
4.7
4.6
mmol/l
0.28
257
2734
13
73
1.81
1.12
2.4
1.6
—
—
—
0
0
19
121
1.60
1.08
2.7
3.3
4.7
4.6
pmol/l
0.20
14
109
29
204
1.46
1.07
6.3
3.0
6.0
4.6
kpa
1.89
29
198
46
591
0.75
1.06
1.4
1.2
7.1
1.1
u/ml
0.61
14
182
11
60
1.86
1.04
1.5
1.8
—
—
—
0
0
204
1867
1.21
1.03
3.9
3.7
12.8
9.7
mm/h
1.49
187
1747
25
353
0.69
1.02
1.2
1.2
13.2
26.8
iu/ml
—
8
100
7
35
2.02
1.00
2.0
2.0
—
—
—
0
0
9
49
1.86
0.99
1.8
1.4
—
—
—
0
0
9
49
1.86
0.99
1.8
1.4
—
—
—
0
0
49
386
1.31
0.94
1.9
1.6
1014.9
1238.0
nmol/l
1.20
35
309
267
2806
0.82
0.92
3.8
3.7
1.5
1.4
mmol/l
0.49
250
2636
6
29
2.09
0.89
1.0
1.1
—
—
—
0
0
6
29
2.09
0.89
1.0
1.1
—
—
—
0
0
10
57
1.78
0.84
1.7
1.5
—
—
—
0
0
38
294
1.33
0.84
3.7
4.0
29.4
29.1
%
0.06
29
219
11
66
1.69
0.79
5.6
2.4
25.2
24.6
mmol/l
0.21
11
59
100
879
1.19
0.75
1.8
1.8
95.4
94.7
pmol/l
0.05
59
504
5
24
2.10
0.75
1.0
1.3
—
—
—
0
0
11
171
0.63
0.74
1.5
1.7
—
—
—
0
0
10
60
1.69
0.73
1.1
1.2
—
—
—
0
0
46
376
1.26
0.70
1.9
1.9
—
—
—
0
0
16
110
1.48
0.69
3.3
2.7
—
—
—
0
0
15
102
1.49
0.68
5.5
10.8
1.9
1.6
%
0.23
15
94
5
91
0.54
0.68
1.0
1.1
—
3.4
—
0
13
12
78
1.56
0.66
1.3
1.1
—
—
—
0
0
7
44
1.60
0.65
1.1
1.2
—
—
—
0
0
207
2192
0.87
0.63
3.3
3.4
54.8
53.0
u/l
0.09
196
2094
12
79
1.54
0.63
1.3
1.1
—
—
—
0
0
8
51
1.58
0.61
1.0
1.1
—
104.6
—
0
15
0
20
0.00
0.60
0.0
2.0
—
—
—
0
0
6
35
1.73
0.58
3.8
1.8
—
—
—
0
0
8
54
1.49
0.57
1.0
1.5
—
—
—
0
0
49
414
1.21
0.57
1.9
2.0
—
—
—
0
0
62
536
1.19
0.57
2.5
2.0
3.0
3.1
mg/l
0.11
53
470
34
276
1.26
0.56
6.6
7.7
—
—
—
0
0
244
2545
0.87
0.56
6.1
5.3
39.5
39.9
mmol/mol
0.27
222
2419
6
37
1.63
0.56
3.8
1.8
—
—
—
0
0
6
38
1.59
0.54
2.5
4.4
—
—
—
0
0
11
74
1.50
0.54
2.8
1.9
—
—
—
0
0
6
39
1.55
0.53
1.5
1.1
—
—
—
0
0
22
170
1.31
0.53
2.6
3.1
86.5
149.5
ng/l
0.96
22
147
101
916
1.14
0.51
2.5
2.6
0.7
0.7
ug/l
0.06
67
520
11
75
1.48
0.51
1.1
1.3
—
—
—
0
0
11
75
1.48
0.51
2.8
1.9
—
—
—
0
0
7
45
1.57
0.49
1.0
1.1
—
—
—
0
0
7
48
1.47
0.47
1.4
1.6
—
—
—
0
0
36
303
1.21
0.45
12.8
11.0
0.5
0.8
mmol/l
0.19
29
244
35
294
1.21
0.45
2.9
1.8
—
—
—
0
0
5
31
1.62
0.43
2.4
1.6
—
—
—
0
0
5
32
1.57
0.42
1.0
1.2
—
—
—
0
0
5
33
1.52
0.41
2.4
1.6
—
—
—
0
0
5
33
1.52
0.41
2.4
1.6
—
—
—
0
0
5
33
1.52
0.41
2.4
1.6
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
62
692
0.87
0.40
1.8
1.7
1.6
1.6
mmol/l
0.02
49
594
5
34
1.48
0.40
2.4
1.6
—
—
—
0
0
5
34
1.48
0.40
2.4
1.6
—
—
—
0
0
5
34
1.48
0.40
2.0
2.3
—
—
—
0
0
53
469
1.15
0.39
1.5
1.6
18.2
18.9
nmol/l
0.15
47
412
31
262
1.20
0.38
14.1
12.2
118.5
125.5
g/l
1.08
31
252
5
36
1.39
0.38
1.2
1.4
—
—
—
0
0
9
69
1.31
0.37
1.0
1.1
—
—
—
0
0
35
301
1.18
0.36
2.9
1.9
—
—
—
0
0
11
81
1.37
0.36
1.1
1.6
—
—
—
0
0
9
71
1.27
0.36
1.8
2.0
9.6
11.0
g/l
—
9
61
6
42
1.44
0.35
1.0
1.1
—
—
—
0
0
6
43
1.40
0.35
1.0
1.1
—
—
—
0
0
102
951
1.10
0.33
4.0
2.6
203.1
189.4
ug/l
0.23
92
888
13
164
0.78
0.31
8.5
11.1
24.0
24.4
mmol/l
0.22
13
152
14
112
1.26
0.28
3.1
3.1
22.8
25.0
mmol/l
1.36
14
105
8
67
1.20
0.26
1.7
2.1
0.1
0.9
g/l
—
8
60
9
72
1.26
0.26
1.1
1.6
—
—
—
0
0
69
742
0.91
0.25
2.6
2.2
127.0
266.8
u/l
3.88
69
703
9
75
1.21
0.25
1.8
2.2
—
1.3
—
0
10
12
96
1.26
0.25
3.8
2.7
—
—
—
0
0
10
79
1.27
0.22
1.6
2.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
1.1
—
0
5
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
7
62
1.13
0.17
1.9
1.8
36.0
37.8
g/l
—
7
51
283
2790
1.07
0.17
24.6
13.4
40.8
42.5
%
2.22
225
2210
130
1256
1.05
0.16
3.0
3.7
22.8
21.2
%
0.55
57
506
227
2314
0.95
0.16
4.1
3.5
1.9
2.4
mu/l
0.45
203
2135
51
479
1.08
0.15
1.6
1.7
402.9
411.6
pmol/l
0.13
40
420
19
171
1.12
0.12
1.9
2.8
64.5
67.1
g/l
0.78
19
158
5
46
1.09
0.09
1.2
1.9
—
—
—
0
0
75
775
0.96
0.09
4.1
4.4
10.4
11.5
mg/mmol
0.09
49
540
5
60
0.83
0.08
1.2
1.8
—
—
—
0
0
7
65
1.08
0.08
1.3
1.1
—
—
—
0
0
8
77
1.04
0.07
1.6
1.6
—
—
—
0
0
64
658
0.97
0.06
3.2
3.3
0.0
0.0
estimate
0.68
29
233
14
131
1.07
0.03
1.3
1.2
—
—
—
0
0
55
538
1.03
0.03
1.4
1.4
—
—
—
0
0
16
151
1.06
0.03
1.3
1.3
—
40.6
—
0
12
93
918
1.02
0.03
2.9
2.2
73.0
71.4
nmol/l
0.22
85
844
179
1802
0.99
0.02
3.7
2.8
15.0
14.8
pmol/l
0.26
162
1642
37
378
0.98
0.01
1.8
1.7
—
—
—
0
0
210
2091
1.01
0.01
2.8
3.0
—
—
—
0
0
50
502
1.00
0.00
3.7
3.7
286.4
932.2
ng/l
1.25
39
377
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
147.3
—
0
9
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
13
130
1.00
0.00
1.1
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
9
96
0.94
0.00
3.0
3.9
—
—
—
0
0
0
6
0.00
0.00
0.0
3.0
—
15.0
—
0
6
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
89.4
—
0
5
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
8
79
1.01
0.00
2.9
2.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
1.3
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_TESTIS_SEMINOMA – Seminoma of testis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).